Synapse - Works

Results (2639)

Current knowledge in genetics, molecular diagnostic tools, and treatments for mantle cell lymphomas

Review

Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Ho, C.
Frontiers in Oncology (2021)

Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy

Meeting Abstract

Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
Quality of Life Research (2021)

Fulltext@MSK | Save

Copanlisib + rituximab versus rituximab + placebo in patients with relapsed follicular (FL) or marginal zone lymphoma (MZL): Subset analysis from the phase III CHRONOS-3 trial

Meeting Abstract

Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yanez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Initial results of the combination of PI3Kδ inhibitor zandelisib (ME-401) and the BTK inhibitor zanubrutinib in patients (pts) with relapsed or refractory (R/R) B-cell malignancies

Meeting Abstract

Soumerai, J. D.; Jagadeesh, D.; Salman, H. S.; Lossos, I. S.; Asch, A. S.; Reddy, N.; Kenkre, V. P.; Pagel, J. M.; Persky, D. O.; Awan, F. T.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Obinutuzumab (G)-atezolizumab (atezo)-lenalidomide (len) for the treatment of relapsed/refractory (R/R) follicular lymphoma (FL): Final analysis of a phase Ib/II trial

Meeting Abstract

Ghosh, N.; Salles, G. A.; Lossos, I. S.; Palomba, M. L.; Mehta, A.; Casasnovas, O.; Stevens, D. A.; Katakam, S.; Knapp, A.; Nielsen, T.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study

Meeting Abstract

Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M. A.; Fenton, K.; Dong, C.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Efficacy and safety of the PI3K delta inhibitor zandelisib (ME-401) on an intermittent schedule (IS) in patients with relapsed/refractory follicular lymphoma (FL) with progression of disease within 24 months of first-line chemoimmunotherapy (POD24)

Meeting Abstract

Pagel, J. M.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Asch, A. S.; Salman, H. S.; Kenkre, V. P.; Soumerai, J. D.; Llorin-Sangalang, J.; Gorbatchevsky, I.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

ESCALADE: A phase 3 study of acalabrutinib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for patients ≤65y with untreated non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Sehn, L. H.; Kahl, B. S.; Matasar, M. J.; Lenz, G.; Izutsu, K.; Zhao, W.; Tao, L.; Calvo, R.; Zinzani, P. L.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Real-world (RW) treatment (tx) patterns and outcomes of 3,455 previously untreated mantle cell lymphoma (MCL) patients (pts) in US routine clinical practice

Meeting Abstract

Martin, P.; Wang, M.; Kumar, A.; Qi, K.; Daly, K.; Parisi, L.; Zhu, A.; Salles, G. A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save